{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:40:42Z","timestamp":1793173242707,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding of China","award":["2022-GSP-TS-8"],"award-info":[{"award-number":["2022-GSP-TS-8"]}]},{"DOI":"10.13039\/501100019031","name":"Chongqing Municipal Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC1107204"],"award-info":[{"award-number":["2020YFC1107204"]}],"id":[{"id":"10.13039\/501100019031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Myocardial bridging (MB) is common in patients with hypertrophic cardiomyopathy (HCM). There are sparse data on the impact of MB on myocardial fibrosis in HCM. This study was designed to evaluate the relationship between MB and myocardial fibrosis in patients with obstructive HCM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cohort study, retrospective data were collected from a high-volume HCM center. Patients with obstructive HCM who underwent septal myectomy and preoperative cardiac magnetic resonance (CMR) were screened from 2011 to 2018.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Finally, 492 patients were included in this study, with an average age of 45.7\u00a0years. Of these patients, 76 patients had MB. MB occurred mostly in the left anterior descending artery (73\/76). The global extent of late gadolinium enhancement (LGE) was correlated with the degree of systolic compression (<jats:italic>r<\/jats:italic>\u2009=\u20090.33, <jats:italic>p<\/jats:italic>\u2009=\u20090.003). Multivariable linear regression analysis revealed that the degree of systolic compression was an independent risk factor for LGE (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20090.292, <jats:italic>p<\/jats:italic>\u2009=\u20090.007). The LGE fraction of basal and mid anteroseptal segments in patients with severe MB (compression ratio\u2009\u2265\u200980%) was significantly greater than that in patients with mild to moderate MB (compression ratio\u2009&lt;\u200980%). During a median follow-up of 28 (IQR: 15\u201352) months, 15 patients died. Kaplan\u2013Meier analysis did not identify differences in all-cause death (log-rank <jats:italic>p<\/jats:italic>\u2009=\u20090.63) or cardiovascular death (log-rank <jats:italic>p<\/jats:italic>\u2009=\u20090.72) between patients undergoing MB-related surgery and those without MB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MB with severe systolic compression was significantly associated with a high extent of fibrosis in patients with obstructive HCM. Concomitant myotomy or coronary artery bypass grafting might provide excellent survival similar to that of patients without MB. Identification of patients with severe MB and providing comprehensive management might help improve the prognosis of patients with HCM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-024-03301-6","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T13:02:31Z","timestamp":1709038951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Changpeng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"issue":"25","key":"3301_CR1","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1161\/CIR.0000000000000938","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142(25):e533\u201357. https:\/\/doi.org\/10.1161\/CIR.0000000000000938.","journal-title":"Circulation"},{"issue":"4","key":"3301_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","volume":"79","author":"BJ Maron","year":"2022","unstructured":"Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(4):372\u201389. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.002.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3301_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","volume":"379","author":"BJ Maron","year":"2018","unstructured":"Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med. 2018;379(7):655\u201368. https:\/\/doi.org\/10.1056\/NEJMra1710575.","journal-title":"N Engl J Med"},{"issue":"22","key":"3301_CR4","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.jacc.2021.09.859","volume":"78","author":"D Sternheim","year":"2021","unstructured":"Sternheim D, Power DA, Samtani R, Kini A, Fuster V, Sharma S. Myocardial bridging: diagnosis, functional assessment, and management: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(22):2196\u2013212. https:\/\/doi.org\/10.1016\/j.jacc.2021.09.859.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3301_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12872-021-02185-1","volume":"21","author":"C Nie","year":"2021","unstructured":"Nie C, Zhu C, Yang Q, Xiao M, Meng Y, Wang S. Myocardial bridging of the left anterior descending coronary artery as a risk factor for atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy: a matched case\u2013control study. BMC Cardiovasc Disord. 2021;21(1):382. https:\/\/doi.org\/10.1186\/s12872-021-02185-1.","journal-title":"BMC Cardiovasc Disord"},{"key":"3301_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.amjcard.2022.10.059","volume":"188","author":"C Bruce","year":"2023","unstructured":"Bruce C, Ubhi N, McKeegan P, Sanders K. Systematic review and meta-analysis of cardiovascular consequences of myocardial bridging in hypertrophic cardiomyopathy. Am J Cardiol. 2023;188:110\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2022.10.059.","journal-title":"Am J Cardiol"},{"issue":"6","key":"3301_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/MAJ.0000000000000194","volume":"347","author":"T Tian","year":"2014","unstructured":"Tian T, Wang YL, Wang JZ, Sun K, Zou YB, Zhang WL, et al. Myocardial bridging as a common phenotype of hypertrophic cardiomyopathy has no effect on prognosis. Am J Med Sci. 2014;347(6):429\u201333. https:\/\/doi.org\/10.1097\/MAJ.0000000000000194.","journal-title":"Am J Med Sci"},{"issue":"39","key":"3301_CR8","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733\u201379. https:\/\/doi.org\/10.1093\/eurheartj\/ehu284.","journal-title":"Eur Heart J"},{"issue":"6","key":"3301_CR9","doi-asserted-by":"publisher","first-page":"H1282","DOI":"10.1152\/ajpheart.00466.2019","volume":"317","author":"M Sharzehee","year":"2019","unstructured":"Sharzehee M, Chang Y, Song JP, Han HC. Hemodynamic effects of myocardial bridging in patients with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2019;317(6):H1282\u201391. https:\/\/doi.org\/10.1152\/ajpheart.00466.2019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"3301_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","volume":"4","author":"MS Maron","year":"2019","unstructured":"Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, et al. Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy. JAMA Cardiol. 2019;4(7):644\u201357. https:\/\/doi.org\/10.1001\/jamacardio.2019.1391.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"3301_CR11","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s10554-020-02153-4","volume":"37","author":"AA Hashi","year":"2021","unstructured":"Hashi AA, Ramesh Prasad GV, Connelly PW, Deva DP, Nash MM, Yuan W, et al. Cardiac MRI assessment of the right ventricle preand postkidney transplant. Int J Cardiovasc Imaging. 2021;37(5):1757\u201366. https:\/\/doi.org\/10.1007\/s10554-020-02153-4.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"3301_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(4):539\u201342. https:\/\/doi.org\/10.1161\/hc0402.102975.","journal-title":"Circulation."},{"issue":"2","key":"3301_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1148\/radiol.2021210914","volume":"302","author":"J Liu","year":"2022","unstructured":"Liu J, Zhao S, Yu S, Wu G, Wang D, Liu L, et al. Patterns of replacement fibrosis in hypertrophic cardiomyopathy. Radiology. 2022;302(2):298\u2013306. https:\/\/doi.org\/10.1148\/radiol.2021210914.","journal-title":"Radiology."},{"issue":"1","key":"3301_CR14","doi-asserted-by":"publisher","first-page":"e0146572","DOI":"10.1371\/journal.pone.0146572","volume":"11","author":"C Zhang","year":"2016","unstructured":"Zhang C, Liu R, Yuan J, Cui J, Hu F, Yang W, et al. Predictive values of N-terminal pro-B-type natriuretic peptide and cardiac troponin I for myocardial fibrosis in hypertrophic obstructive cardiomyopathy. PLoS One. 2016;11(1):e0146572. https:\/\/doi.org\/10.1371\/journal.pone.0146572.","journal-title":"PLoS One"},{"issue":"4","key":"3301_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","volume":"5","author":"MS Maron","year":"2012","unstructured":"Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, et al. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2012;5(4):441\u20137. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.972760.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"19","key":"3301_CR16","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","volume":"108","author":"P Sorajja","year":"2003","unstructured":"Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation. 2003;108(19):2342\u20138. https:\/\/doi.org\/10.1161\/01.CIR.0000097110.55312.BF.","journal-title":"Circulation"},{"issue":"13","key":"3301_CR17","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","volume":"30","author":"C Basso","year":"2009","unstructured":"Basso C, Thiene G, Mackey-Bojack S, Frigo AC, Corrado D, Maron BJ. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J. 2009;30(13):1627\u201334. https:\/\/doi.org\/10.1093\/eurheartj\/ehp121.","journal-title":"Eur Heart J"},{"issue":"17","key":"3301_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJM199810223391704","volume":"339","author":"AT Yetman","year":"1998","unstructured":"Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy\u2013a risk factor for sudden death. N Engl J Med. 1998;339(17):1201\u20139. https:\/\/doi.org\/10.1056\/NEJM199810223391704.","journal-title":"N Engl J Med"},{"issue":"3","key":"3301_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ijcard.2006.12.062","volume":"124","author":"SV Brodsky","year":"2008","unstructured":"Brodsky SV, Roh L, Ashar K, Braun A, Ramaswamy G. Myocardial bridging of coronary arteries: a risk factor for myocardial fibrosis? Int J Cardiol. 2008;124(3):391\u20132. https:\/\/doi.org\/10.1016\/j.ijcard.2006.12.062.","journal-title":"Int J Cardiol"},{"issue":"7","key":"3301_CR20","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/s0735-1097(98)00493-8","volume":"32","author":"AT Yetman","year":"1998","unstructured":"Yetman AT, Hamilton RM, Benson LN, McCrindle BW. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1998;32(7):1943\u201350. https:\/\/doi.org\/10.1016\/s0735-1097(98)00493-8.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03301-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-024-03301-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03301-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T13:15:19Z","timestamp":1709039719000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-024-03301-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3301"],"URL":"https:\/\/doi.org\/10.1186\/s12916-024-03301-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Fuwai Hospital (2017\u2013887). All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the paper content and agreed to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}